Why invest in Artivion, Inc. : (NYSE:AORT) as the global cardiovascular devices market soars?
Artivion, Inc.(NYSE: AORT) is a distributor of cryogenically preserved human tissues for cardiac and vascular transplant applications and develops medical devices. Among its products are human heart valves, which are treated to remove excess cellular material and antigens, and BioGlue surgical adhesive.
It was the first biomedical company to specialize in ultra-low temperature preservation of human heart valves used for cardiac reconstruction, primarily in children born with heart defects. It preserves and distributes human tissues and develops, manufactures, and commercializes medical devices for cardiac and vascular transplant applications.